Massive Short Squeeze in CanopyCanopy is on fire today, and is up 20% plus on the week, off the back of optimism over the possible decriminalization of Marijuana in the United States. Last night at the Vice Presidential Debate, Kamala Harris made mention of the dems plan to bring this to fruition, should they win the election in November. This has the entire sector hot today, without exception, as one can expect.
It looks as though we may hit the 200 day MA at 23.30 this week before we see profit taking, and the shorts re-entering. It's also important to note that we're nearing major resistance with the top of the downward channel a stones throw away. I suspect we may see a reversal of the squeeze next week once the bulls have achieved these levels. If there's enough momentum to pierce the upper downtrend line, and the 200 day MA, the upside could be massive, particularly seeing as earnings are not until early November.
We shouldn't rule out the possibility of a broad market sell off, given the high number of potential catalysts floating around at the moment. This could heavily affect Canopy's price action, and the positive sentiment around it's valuation.
I appreciate your time today guys. Thanks, Michael.
If you like our analysis, please hit the Like button and subscribe to our profile so you don't miss our new analysis and updates.
The information and analysis shared in this post is not financial advice. Always conduct your own analysis and research.
Cannabis
CHM.C -- Biomedical/Cannabis play trading below cash positionCHM.C is breaking out on record volume!
The company had $4M in cash at the end of May. The enterprise value of CHM is about $8.5M. Options (.06, .10) and warrants (.50, .70) were issued at significantly higher levels than current stock price. Insiders and consultants hold over 35% of the float.
Cannabis sector is starting to wake up a little but it is the Biomedical angle that has me intrigued about CHM. It has acquired a 16.4% stake ImmunoFlex Therapeutics, the company developing products to enhance immunological responsiveness. It is clear that, once released, they will be marketed in the context of COVID-19 pandemic as preventative and immune system strengthening treatments.
While the target date for ImmunoFlex products release was vague (“late Fall 2020”), there are signs that it will come sooner rather than later. On September 28th, ImmunoFlex announced hiring of prominent medical professionals and established a Scientific Advisory Board. I suspect we will be seeing more news very soon.
On the Cannabis side of things, CHM has recently expanded its Sugarleaf cultivation facility in Washington State by ~ 30%. They are also in the early stages of establishing a California-based operation.
Greenlane Holdings Imminent Golden CrossI bought August 26th thinking that day was a great "higher low". I stand by that purchase too. Buy it under $13 for a steal. LMAO. Get a clue America. You've been duped already. FAANG hype mania 2020. Get wrecked media pamping. Overleveraged bubblicious large caps. #cannabisboom2020 #mci #watchthis #gnln #federalize
Linktree RiskSavage
ACB BUY (AURORA CANNABIS INC)Hi there. Price is forming a continuation pattern to the upside. Watch strong price action at the current levels for buy.
ACB Aurora Cannabis slow deathWaiting for a some sings of life to turn bullish. Has a lot of potential and a good one to watch
$RNWF 3rd Major Company Could Become Holding Company for $RVDO$RNWF On A Breakout today, DD points towards majority stakeholder in $RVDO possibly becoming a holding company with other companies underneath it. Right now it is all speculation, and hearsay, but the connections are becoming too apparent to ignore. Could the company also be holding shares in $GRNF? Time will tell.
To find more DD check the links below.
Looking for a breakout of .015 to the upside of .05+ on this second major leg up
Are we finally finding a bottom?I had published a previous chart on HMMJ, which for now has failed, overshooting to the downside. I have to believe so much bad news has been priced into the sector. There are a couple of positive catalysts that may provide the lift needed to gain favor with investors.
ACB updateStill bearish and looking for some kind of bottom around ~8.75. Show a potential alternate bearish count for a lower wave C
ACB Aurora CannabisDon't like the look of the impulse/correction and still think ~ 8.76 is looking like a good potential entry if I see 5 waves down
ACB Aurora Cannabis updatePotential bottom but need 5 waves and nice correction before before turning more bullish
An alternative way to play $GWGR and $IIPR. #420FA,
- 6.8% dividend
- $IIPR 10% weighting
- $GWGR 9.56% weighting
- Cannabis > alcohol
- Cannabis has the potential to disrupt big tobacco
- Lower stigma + more acceptance in society
- Gary Vee
TA,
- Reversing long term downtrend
-Daily MACD cross
- Short term moving average crossover
Nice play to get exposure to $IIPR and $GWGR.
Let's go 'Higher'.
HEXO BUY (HEXO CORP)Hi there. Price is forming a continuation pattern to the upside. Watch strong price action at the current levels for buy.
SNDL SUNDIAL GROWERS INC upside potentialAug 13 (Reuters): NET CANNABIS REVENUE FOR Q2 OF 2020 WAS $20.2 MILLION, AN INCREASE OF 44% OVER Q1 OF 2020
Sundial Growers, Inc. engages in the production and distribution of flower, pre-rolls and vapes. It operates through the following segments: Cannabis, Ornamental Flowers, and Corporate.
6/29/2020 BMO Capital Markets Upgrade Underperform ➝ Market Perform target price $1.00
Market cap: 75.147M
Net Income: $-204,570,000
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
ACB updateShow some of the price targets I'm watching for right now. It looks decent right now. Don't love the 3rd wave start yet. Watching for it to stay above ~10.13 and bearish if goes below ~10
ACB looking for bottomACB staying choppy but still remains a good opportunity once bottom is struck.